PT1144425E - Derivados de monossacaridos como inibidores de adesao celular - Google Patents

Derivados de monossacaridos como inibidores de adesao celular

Info

Publication number
PT1144425E
PT1144425E PT00900087T PT00900087T PT1144425E PT 1144425 E PT1144425 E PT 1144425E PT 00900087 T PT00900087 T PT 00900087T PT 00900087 T PT00900087 T PT 00900087T PT 1144425 E PT1144425 E PT 1144425E
Authority
PT
Portugal
Prior art keywords
monosacaridos
inhibitors
derivatives
cell adhesion
adhesion
Prior art date
Application number
PT00900087T
Other languages
English (en)
Inventor
Sudershan K Arora
Jang Bahadur Gupta
Madan P Tanwar
Geeta Sharma
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PT1144425E publication Critical patent/PT1144425E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00900087T 1999-01-12 2000-01-10 Derivados de monossacaridos como inibidores de adesao celular PT1144425E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22915599A 1999-01-12 1999-01-12
US09/411,357 US6329344B1 (en) 1998-10-22 1999-10-01 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
PT1144425E true PT1144425E (pt) 2004-10-29

Family

ID=26922990

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00900087T PT1144425E (pt) 1999-01-12 2000-01-10 Derivados de monossacaridos como inibidores de adesao celular

Country Status (29)

Country Link
US (1) US6329344B1 (pt)
EP (1) EP1144425B1 (pt)
JP (1) JP2002534529A (pt)
CN (1) CN1254478C (pt)
AR (1) AR033939A1 (pt)
AT (1) ATE269349T1 (pt)
AU (1) AU767948B2 (pt)
BG (1) BG105795A (pt)
BR (1) BR0007489A (pt)
CA (1) CA2359980A1 (pt)
CO (1) CO5170511A1 (pt)
CZ (1) CZ20012541A3 (pt)
DE (1) DE60011568T2 (pt)
DK (1) DK1144425T3 (pt)
ES (1) ES2223447T3 (pt)
HK (1) HK1041006B (pt)
HR (1) HRP20010527B1 (pt)
HU (1) HUP0200097A3 (pt)
ID (1) ID30259A (pt)
IL (2) IL144274A0 (pt)
MA (1) MA25679A1 (pt)
MY (1) MY122723A (pt)
NZ (2) NZ512851A (pt)
PA (1) PA8489601A1 (pt)
PT (1) PT1144425E (pt)
SK (1) SK284568B6 (pt)
TR (1) TR200102031T2 (pt)
WO (1) WO2000042053A1 (pt)
YU (1) YU50101A (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
AU2003202767A1 (en) * 2003-02-12 2004-09-06 Ranbaxy Laboratories Limited Preparation of monosaccharide derivatives
WO2004099229A1 (en) * 2003-05-06 2004-11-18 Ranbaxy Laboratories Limited Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides
CA2753318A1 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
US20060004005A1 (en) * 2003-09-25 2006-01-05 Sattigeri Viswajanani J Triazines derivatives as cell adhesion inhibitors
WO2005092908A1 (en) * 2004-03-18 2005-10-06 Ranbaxy Laboratories Limited Base addition salts of monosaccharides derivatives as inhibitors of airway hyper reactivity and airway inflammation
WO2005092907A2 (en) * 2004-03-26 2005-10-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
WO2005100373A2 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
US20090221515A1 (en) * 2004-09-02 2009-09-03 Viswajanani Jitendra Sattigeri Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
EP1842855A3 (en) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
EP1953170A1 (en) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory agents
CN105367612A (zh) * 2014-08-13 2016-03-02 中国药科大学 龙脷叶由来天然产物丁基2-脱氧-3，6-脱水-β-D-阿拉伯糖呋喃糖苷的全合成方法
US20220356150A1 (en) * 2021-04-30 2022-11-10 Evoco Limited Biobased diisocyanates, and process for preparation of same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
DE2936240A1 (de) * 1979-09-07 1981-03-26 Bayer Ag, 51373 Leverkusen Verfahren zur herstellung bekannter und neuer 6-amino-6-desoxy-2,3-0-isopropyliden-(alpha)-l-sorbofuranose-derivate sowie neue zwischenprodukte des verfahrens
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5298494A (en) 1989-01-09 1994-03-29 Greenwich Pharmaceuticals Incorporated Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
IL100833A0 (en) 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
US5360792A (en) 1991-12-20 1994-11-01 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
US5360794A (en) 1992-08-03 1994-11-01 Medicarb Inc. Disubstituted and deoxy disubstituted derivatives of α-D-mannofuranosides and β-L-gulofuranosides having anti-inflammatory and anti-proliferative activity
US5367062A (en) 1992-08-21 1994-11-22 Medicarb Inc. Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity
US5508387A (en) * 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
JPH09504522A (ja) * 1993-10-12 1997-05-06 グリコメド・インコーポレイテッド 細胞接着インヒビターの同定に有用なグリコ−ペプチドのライブラリー
US5637570A (en) 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
US5919769A (en) * 1995-10-26 1999-07-06 Kanebo, Ltd Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same
US5824657A (en) 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders

Also Published As

Publication number Publication date
IL144274A0 (en) 2002-05-23
US6329344B1 (en) 2001-12-11
YU50101A (sh) 2005-07-19
PA8489601A1 (es) 2000-09-29
HUP0200097A2 (hu) 2002-05-29
AU1886000A (en) 2000-08-01
WO2000042053A1 (en) 2000-07-20
EP1144425A1 (en) 2001-10-17
CN1254478C (zh) 2006-05-03
DK1144425T3 (da) 2004-10-18
TR200102031T2 (tr) 2001-12-21
CZ20012541A3 (cs) 2002-02-13
HUP0200097A3 (en) 2003-03-28
CO5170511A1 (es) 2002-06-27
HK1041006A1 (en) 2002-06-28
SK9962001A3 (en) 2002-02-05
ATE269349T1 (de) 2004-07-15
BG105795A (en) 2002-05-31
AR033939A1 (es) 2004-01-21
IL144274A (en) 2007-05-15
CA2359980A1 (en) 2000-07-20
ID30259A (id) 2001-11-15
DE60011568T2 (de) 2005-08-18
ES2223447T3 (es) 2005-03-01
AU767948B2 (en) 2003-11-27
EP1144425B1 (en) 2004-06-16
SK284568B6 (sk) 2005-06-02
CN1343212A (zh) 2002-04-03
MA25679A1 (fr) 2003-04-01
MY122723A (en) 2006-04-29
HRP20010527B1 (en) 2005-06-30
NZ527482A (en) 2005-02-25
DE60011568D1 (de) 2004-07-22
NZ512851A (en) 2004-02-27
HK1041006B (zh) 2005-02-04
JP2002534529A (ja) 2002-10-15
HRP20010527A2 (en) 2002-08-31
BR0007489A (pt) 2002-01-02

Similar Documents

Publication Publication Date Title
PT1144425E (pt) Derivados de monossacaridos como inibidores de adesao celular
PT1220831E (pt) Novos derivados eter biarilico uteis como inibidores de recaptacao de monoamina
PT1185529E (pt) Pirazolobenzodiazepinas como inibidores de cdk2
PT1042287E (pt) Derivados de indole como inibidores do factor xa
PT1244647E (pt) Derivados de quinazolina como inibidores de vegf
ATE330935T1 (de) Inhibitoren der alpha4 vermittelten zelladhäsion
PT1001934E (pt) Compostos de indole como inibidores de cox-2
PT1165516E (pt) Ureia heterociclica e compostos relacionados, uteis como agentes anti-inflamatorios
DE60008527D1 (de) Zellproliferation inhibitoren
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
AR028575A1 (es) Derivados de pirrolopiridinona utiles como inhibidores de fosfodiesterasa
PT1060178E (pt) Compostos heterociclicos como inibidores de enzimas rotamase
PT1212320E (pt) Fenilpiperazinas como inibidores de reabsorcao de serotonina
PT1097127E (pt) Derivados de diacil-hidrazina como inibidores da integrina
PT1226143E (pt) Derivados de imidazopiridina como inibidores da fosfodiesterase vii
PT1189907E (pt) Tienopirimidinas como inibidores da fosfodiesterase
FI19992855A (fi) Valaisuolosuhteiden mittaus
PT1155013E (pt) Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina
PT1216250E (pt) Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4
PT1147119E (pt) Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular
DE60024101D1 (de) Enzyminhibitoren
PT1222193E (pt) Derivados de imidazol como inibidores da fosfodiesterase
DE60009296D1 (de) Substituierte purine-derivate als zell-adhäsionhemmer
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20022682L (no) Heterosykliske derivater